13
buffer capacity of biologics-from buffer salts to buffering by antibodies.pdf
buffer capacity of biologics—from buffer salts to buffering by antibodies
13
a cell-free expression and purification process for rapid production of protein biologics.pdf
a cell-free expression and purification process for rapid production of protein biologics
17
peptide-based supramolecular hydrogels for delivery of biologics.pdf
peptide-based supramolecular hydrogels for delivery of biologics
20
Stimulating Innovation in the Biologics Industry_ A Balanced Approach to Marketing Exclusivity.pdf
Stimulating Innovation in the Biologics Industry_ A Balanced Approach to Marketing Exclusivity.pdfin,A,to,the
9
cost-effectiveness of biologics in polyarticular-course juvenile idiopathic arthritis patients unresponsive to disease-modifying antirheumatic drugs.pdf
cost-effectiveness of biologics in polyarticular-course juvenile idiopathic arthritis patients unresponsive to disease-modifying antirheumatic drugs
24
Comparability Protocols for Human Drugs and Biologics.pdf
Comparability Protocols for Human Drugs and Biologics
13
clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology.pdf.目的临床和监管角度为治疗和副本rheumatology.pd.pdf
clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology.pdf.目的临床和监管角度为治疗和副本rheumatology.pd

向豆丁求助:有没有biologics?

如要投诉违规内容,请联系我们按需举报;如要提出意见建议,请到社区论坛发帖反馈。